Physician profile
Symone Stephens
NPI 1124638184
$1,247.48
in general payments reported to CMS, 2019-2025
11 companies · $337 in 2025
The $337 reported for 2025 was more than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $46.19 · 2022: $248 · 2023: $513 · 2024: $103 · 2025: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $769 · Education: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $768.76 |
| Education | $184.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $483.16 | 2023-2024 | Veozah, Myrbetriq |
| Viiv Healthcare Company | $212.57 | 2025 | Apretude |
| Agile Therapeutics, INC. | $135.39 | 2022 | |
| Gilead Sciences, INC. | $124.80 | 2025 | Yeztugo |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $99.98 | 2023 | |
| Exeltis, USA INC. | $65.50 | 2022 | |
| Pfizer INC. | $34.22 | 2022-2023 | |
| Hologic Sales and Service, LLC | $31.10 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $26.71 | 2021-2023 | Vaxneuvance, Rotateq, Gardasil 9 |
| Mylan Pharmaceuticals INC. | $19.01 | 2021 | |
| Shield Therapeutics INC | $15.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Symone Stephens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.